Cancer BiologybioRxivPreprint
Replication competent adenoviral platform for in situ production of immunotherapeutic RNA aptamers targeting 4 1BB
Antonio Tallón, Virginia Laspidea, Iker Ausejo‐Mauleon…·Marc Garcia Moure
This paper develops a replication-competent adenovirus platform for in situ production of RNA aptamers targeting 4-1BB, showing antitumor activity comparable to a 4-1BBL-expressing adenovirus.
DOI 10.64898/2026.03.01.708858